Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 349)
Posted On: 05/25/2021 9:54:00 AM
Post# of 36564
Posted By: pacsurg21
Re: rvbpk #29633
This is an excellent discussion topic. My take is less granular. GNBT is still parent for NGIO and owns ~60% of NGIO + all decision making. How does this not carry GNBT to have a more positive pps? I do get the linear property of GNBT owning A shares, but they still own 60% of the company and have the power to unify shares at any conversion factor they choose at anytime. I would think that we would see a price alignment occur upon IPO or at least after GNBT can submit its next quarterly statement as the value of NGIO will be recognized on its balance sheet.

Current EPS = -.56
# of shares = 114.95MM
NGIO tentative valuation @ $9/share = $500MM
New asset is added to Bal Sheet at $300MM
Less current debt of $64.372MM
New asset provides positive $235,628,000 of new company value.
PPS is $2.05 at minimum.

Concerns: obv this is not yet to the $4 Nasdaq mark, abd so could still be messed with on the OTC, so it’ll be great when NGIO hits $1BB in valuation as it will easily propel GNBT to Nasdaq levels.













(6)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site